Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Patents

Parbendazole For Use In The Treatment Of Dementia - PCT

AlzheimerPatent

12.09.2024

Parbendazole For Use In The Treatment Of Dementia - PCT from TRUSTLIFE

Abstract:

There is provided a product for use in a method of prevention or treatment of dementia, wherein the product is or bortezomib or parbendazole.

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models
    Scientific Documents

    Multi-Target Neuroprotective Compound Exhibits EAAT2-Modulating and Alzheimer’s Pathology–Attenuating Effects in In Vitro and In Vivo Models

  • Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026
    Recent News

    Clinical Application for the First National Alzheimer’s Drug – Trustlife Press Release – 20.02.2026

Trustlife
About Trustlife Labs Drug R&D Center Contact